...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary: in regard to Al Yami et al. (Int J Radiat Oncol Biol Phys 2010;77:1191-1197).
【24h】

Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary: in regard to Al Yami et al. (Int J Radiat Oncol Biol Phys 2010;77:1191-1197).

机译:术前放疗治疗的软组织肉瘤的手术切缘阳性:是对Al Yami等人的术后增强。 (Int J Radiat Oncol Biol Phys 2010; 77:1191-1197)。

获取原文
获取原文并翻译 | 示例
           

摘要

We credit Al Yami et al. for addressing the value of postoperative boost radiation in soft tissue sarcoma patients with positive margins after 50 Gy of preoperative radiotherapy. It is worth commenting that postoperative boost radiotherapy was formerly used in patients with negative margins, until data from Sadoski et al. (1) demonstrated that it could be eliminated.The authors compared 41 patients receiving 50 Gy of preoperative radiotherapy and a postoperative external beam radiotherapy boost with 52 patients who did not receive a boost. They reported no local control advantage, with a 5-year local control rate of 90.4% in the no-boost group vs. 73.8% in the boost group (p = .13). Series of patients with positive surgical margins who received adjuvant radiotherapy documented a local control rate of ~70%, suggesting the no-boost group here was carefully selected (2, 3). There is likely value in identifying patients for whom a boost is not necessary. Indeed, the Princess Margaret group has identified patients with (1) a positive margin in a low-grade, well-differentiated liposarcoma or (2) "planned positive" margin on an anatomically fixed critical structure as at low risk of local recurrence (4.2% and 3.6%, respectively) (4). In contrast, there are patients with a poor histologic response, margins broadly or multifocally positive, margins positive after re-excision, and "unplanned positive margins" (4), for whom additional treatment, if effective, is likely warranted.
机译:我们相信Al Yami等人。评估术前放疗50 Gy后边缘阳性的软组织肉瘤患者术后加强放疗的价值。值得一提的是,术后一直使用加强放疗来治疗负切缘的患者,直到获得Sadoski等人的数据。 (1)证明可以消除。作者比较了接受50 Gy术前放疗和术后外照射放疗加强的41例患者与未接受加强放疗的52例患者。他们报告没有本地控制优势,无助推组的5年本地控制率为90.4%,而加强组为73.8%(p = 0.13)。一系列接受辅助放疗的手术切缘阳性的患者证明局部控制率为〜70%,这表明这里精心选择了无助推疗法的人群(2、3)。确定不需要加强治疗的患者可能具有价值。的确,玛格丽特公主小组已确定患者(1)在低度分化良好的脂肪肉瘤中为阳性切缘,或(2)在解剖学上固定的关键结构上为“计划为阳性”切缘的患者,其局部复发风险较低(4.2 %和3.6%)(4)。相反,有些患者的组织学反应较差,切缘广泛或多灶阳性,再次切除后切缘阳性,以及“计划外切缘阳性”(4),因此可能需要进行额外的治疗,如果有效的话。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号